Replies to post #142 on Sio Gene Therapies Inc (fka SIOX)

[jerseyboy]

I think so, but they're volatile (look at ABEO as an example, although I still have confidence in their long-term prospects). If management is sound and stable and they have what appears to be a good pipeline that addresses significant unmet needs, I think they have the potential to be very rewarding. SIOX got punished for the snag in the manufacturing process development by Oxford, but I think it was unduly so and temporary, and I think its valuation is considerably lower than what it should be at this point, as $143.9 million seems to be much lower than comparable companies with similar prospects.